BP40 MULTICENTER PHASE II STUDY OF APATINIB, A NOVEL INHIBITOR OF VEGFR, IN HEAVILY PRETREATED PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER

✍ Scribed by Hu, Xi-chun; Zhang, Jian; Xu, Bing-he; Jiang, Ze-fei; Tong, Zhong-sheng; Zhang, Qing-yuan; Wang, Xiao-jia; Feng, Ji-feng; Pang, Dan-mei; Fan, Min-hao; Li, Jin; Wang, Bi-yun; Wang, Zhong-hua; Zhang, Qun-ling; Sun, Si; Liao, Chun-mei; Jiang, Hao-yuan; Shao, Zhi-min

• Book ID: 122113559
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 53 KB
• Volume: 22
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/S0960-9776(13)70054-7